Menu

Find clinical trials for Ovarian Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer
A woman searches for clinical trials

Ovarian Cancer trials near Houston, TX, USA:

To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy

Enrolling
Ovarian Cancer
Other: Shared Medical Decision Tool
Behavioral: Engaging Patients in Decision Making
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...

Enrolling
Primary Peritoneal Cancer
Platinum-refractory Ovarian Cancer
Drug: Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin
Drug: Platinum chemotherapy: carboplatin (preferred) or cisplatin

Phase 3

Genelux

Houston, Texas, United States and 25 other locations

To learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer....

Enrolling
Ovarian Cancer
Drug: Lurbinectedin
Drug: Bevacizumab

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian ...

Enrolling
Ovarian Cancer
Cholangiocarcinoma Recurrent
Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR

Phase 1

Verismo Therapeutics

Houston, Texas, United States and 3 other locations

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

The Woodlands, Texas, United States and 46 other locations

This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...

Active, not recruiting
Ovarian Neoplasms
Abdominal Neoplasm
Biological: AB-1015

Phase 1

ArsenalBio

Houston, Texas, United States and 9 other locations

To learn if adding etigilimab to nivolumab therapy can help to control clear cell ovarian, fallopian tube, and primary peritoneal cancers...

Enrolling
Ovarian Cancer
Drug: Nivolumab
Drug: Etigilimab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

The Woodlands, Texas, United States and 20 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Houston, Texas, United States and 176 other locations

phase the preliminary efficacy in subjects with ARID1a mutated ovarian clear cell and ovarian endometrioid cancers will be...

Enrolling
Ovarian Clear Cell Carcinoma
Ovarian Clear Cell Adenocarcinoma
Drug: NXP800

Phase 1

Nuvectis Pharma

Houston, Texas, United States and 22 other locations